Cargando…
Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol
INTRODUCTION: In recent years, there has been increasing interest in the use of spirometry for the assessment of small airways obstruction (SAO) driven by the idea that these changes occur prior to development of established obstructive lung disease. Maximal mid-expiratory and distal flow rates have...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493897/ https://www.ncbi.nlm.nih.gov/pubmed/34610942 http://dx.doi.org/10.1136/bmjopen-2021-052931 |
_version_ | 1784579207666335744 |
---|---|
author | Knox-Brown, Ben Mulhern, Octavia Amaral, Andre F S |
author_facet | Knox-Brown, Ben Mulhern, Octavia Amaral, Andre F S |
author_sort | Knox-Brown, Ben |
collection | PubMed |
description | INTRODUCTION: In recent years, there has been increasing interest in the use of spirometry for the assessment of small airways obstruction (SAO) driven by the idea that these changes occur prior to development of established obstructive lung disease. Maximal mid-expiratory and distal flow rates have been widely used despite a lack of agreement regarding parameter selection or definition of an abnormal result. We aim to provide evidence from population-based studies, describing the different parameters, definitions of normal range and the resulting impact on prevalence estimates for SAO. Summarising this evidence is important to inform development of future studies in this area. METHODS AND ANALYSIS: A systematic review of population-based studies will be conducted. MEDLINE, Web of Science and Google Scholar will be searched from database inception to May 2021. Primary outcomes will include the spirometry parameter used to define SAO, and the definition of an abnormal result. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed for study selection. Study methods will be assessed using the Newcastle-Ottawa scale and the Grading of Recommendations Assessment, Development and Evaluation working group methodology. Narrative synthesis will be conducted for all included studies. Meta-analysis will also be conducted for prevalence estimates and associated risk factors where data quality and availability allow. Random effects models will be used to conduct the meta-analysis and I(2) statistics will be used to assess heterogeneity across studies. Where appropriate subgroup analysis will be conducted to explore heterogeneity. ETHICS AND DISSEMINATION: There is no requirement for ethical approval for this project. Findings will be disseminated via peer-reviewed publications and other formats, for example, conferences, congresses or symposia. PROSPERO REGISTRATION NUMBER: CRD42021250206. |
format | Online Article Text |
id | pubmed-8493897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84938972021-10-14 Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol Knox-Brown, Ben Mulhern, Octavia Amaral, Andre F S BMJ Open Epidemiology INTRODUCTION: In recent years, there has been increasing interest in the use of spirometry for the assessment of small airways obstruction (SAO) driven by the idea that these changes occur prior to development of established obstructive lung disease. Maximal mid-expiratory and distal flow rates have been widely used despite a lack of agreement regarding parameter selection or definition of an abnormal result. We aim to provide evidence from population-based studies, describing the different parameters, definitions of normal range and the resulting impact on prevalence estimates for SAO. Summarising this evidence is important to inform development of future studies in this area. METHODS AND ANALYSIS: A systematic review of population-based studies will be conducted. MEDLINE, Web of Science and Google Scholar will be searched from database inception to May 2021. Primary outcomes will include the spirometry parameter used to define SAO, and the definition of an abnormal result. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed for study selection. Study methods will be assessed using the Newcastle-Ottawa scale and the Grading of Recommendations Assessment, Development and Evaluation working group methodology. Narrative synthesis will be conducted for all included studies. Meta-analysis will also be conducted for prevalence estimates and associated risk factors where data quality and availability allow. Random effects models will be used to conduct the meta-analysis and I(2) statistics will be used to assess heterogeneity across studies. Where appropriate subgroup analysis will be conducted to explore heterogeneity. ETHICS AND DISSEMINATION: There is no requirement for ethical approval for this project. Findings will be disseminated via peer-reviewed publications and other formats, for example, conferences, congresses or symposia. PROSPERO REGISTRATION NUMBER: CRD42021250206. BMJ Publishing Group 2021-10-05 /pmc/articles/PMC8493897/ /pubmed/34610942 http://dx.doi.org/10.1136/bmjopen-2021-052931 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Knox-Brown, Ben Mulhern, Octavia Amaral, Andre F S Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title | Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title_full | Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title_fullStr | Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title_full_unstemmed | Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title_short | Spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
title_sort | spirometry parameters used to define small airways obstruction in population-based studies: systematic review protocol |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493897/ https://www.ncbi.nlm.nih.gov/pubmed/34610942 http://dx.doi.org/10.1136/bmjopen-2021-052931 |
work_keys_str_mv | AT knoxbrownben spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreviewprotocol AT mulhernoctavia spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreviewprotocol AT amaralandrefs spirometryparametersusedtodefinesmallairwaysobstructioninpopulationbasedstudiessystematicreviewprotocol |